(VIANEWS) – The NASDAQ opens in less than five hours and Inovio Pharmaceuticals‘s pre-market value is already 5.26% up.
The last session, NASDAQ ended with Inovio Pharmaceuticals (INO) rising 3.64% to $2.28. NASDAQ jumped 0.41% to $12,720.58, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session.
Today’s last reported volume for Inovio Pharmaceuticals is 6902414, 2.52% below its average volume of 7081235.
Inovio Pharmaceuticals’s last close was $2.28, 77.11% under its 52-week high of $9.96.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 138.1% for the ongoing quarter and a decline by 33% for the next. The company’s growth estimates for the current quarter is 17.9% and a drop 3.4% for the next.
Inovio Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 3.64%, 5.40%, and 5.61%, respectively.
Inovio Pharmaceuticals’s highest amplitude of average volatility was 6.42% (day), 7.66% (last week), and 9.49% (last month), respectively.
More news about Inovio Pharmaceuticals (INO).